Summary of "Every fourth tablet consumed globally is made in India. We have come a long way in producing affordable, high-quality medicines for the world," said Rajeev Juneja, VC and MD, Mankind Pharma | Entrepreneur

  • entrepreneur.com
  • Article
  • Summarized Content

    html

    India's Healthcare: A Collaborative Approach

    The article highlights the rapid growth of India's healthcare market and the crucial role of collaboration between the public and private sectors to ensure accessible, affordable, and high-quality healthcare for all.

    • Madhukar Kumar Bhagat, Joint Secretary, Union Ministry of Health and Family Welfare, emphasizes the need for partnerships to bridge the gaps in healthcare access, particularly in rural areas.
    • The government's vision for a "Vikshit Bharat" (Developed India) emphasizes people-centric healthcare as a key pillar, highlighting the importance of availability, affordability, access, and quality.
    • Technological advancements, especially in Artificial Intelligence (AI), are being leveraged to enhance healthcare services across India.

    India: A Global Pharma Powerhouse

    The article discusses India's emergence as a leading player in the global pharmaceutical landscape, with Indian companies producing a significant portion of the world's medicines.

    • Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma, emphasizes the role of Indian pharmaceutical companies in providing affordable, high-quality medicines globally.
    • Dr. Shefali Misra, Group Vice President of Public Policy & Government Affairs at Biocon Group, highlights India's commitment to developing and manufacturing biosimilars and biologics, addressing the global need for affordable treatments.
    • India's pharmaceutical industry is a major drug manufacturer globally, with exports of drugs and pharmaceuticals reaching USD 25.4 billion in FY23, projected to exceed USD 31 billion in the next financial year.

    Addressing Antimicrobial Resistance (AMR) in India

    The article sheds light on the critical issue of antimicrobial resistance (AMR) and the need for innovation and investment in India to combat this growing public health challenge.

    • Dr. Sangeeta Sharma, Professor and Head of Neuropsychopharmacology at the Institute of Human Behaviour & Allied Sciences (IHBAS), stresses the urgency to invest in new antibiotics and diagnostic tools to combat AMR.
    • Industry collaboration is crucial to raise awareness, improve surveillance, and ensure quality control, utilizing modern technologies like AI to address AMR effectively.
    • The article highlights the need for innovation in diagnostics, new antibiotics, and preservation of existing antibiotics to fight AMR effectively.

    India's Global Healthcare Initiatives

    The article emphasizes India's commitment to promoting affordable and quality healthcare not just within its borders but also globally, showcasing its collaborations with international organizations.

    • Genessa Giorgi, Health Attaché at the U.S. Embassy, highlights India's global initiatives and its partnership with the United Nations to advance healthcare innovation.
    • The article underscores the potential for India to become a hub for pharma and biotech startups, with significant investments in R&D and AI-based pharma IT hubs.

    Key Takeaways: India's Healthcare Landscape

    • India's healthcare market is growing rapidly, driven by public-private partnerships.
    • Indian pharmaceutical companies play a crucial role in global healthcare, providing affordable medicines worldwide.
    • Addressing antimicrobial resistance (AMR) is a key challenge, requiring innovation and investment in India.
    • India is committed to global healthcare initiatives, promoting innovation and collaboration on a global scale.

    Discover content by category

    Ask anything...

    Sign Up Free to ask questions about anything you want to learn.